Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A South Korean IVD company developing and manufacturing diagnostic tests and reagents for clinical laboratories.
Diagnostics
Technology Platform
A platform for developing and manufacturing a range of in vitro diagnostic tests, likely based on immunoassay and/or molecular diagnostic technologies.
Opportunities
Opportunities exist in developing tests for localized disease outbreaks, forming OEM partnerships, and expanding into emerging markets with cost-effective products.
Risk Factors
Key risks include pricing pressure from larger competitors, commoditization of routine tests, and the high cost of regulatory compliance for new markets.
Competitive Landscape
Faces intense competition from large, global IVD corporations that benefit from vast R&D budgets and established commercial footprints.